tiprankstipranks
Trending News
More News >
MiMedx Group Inc. (MDXG)
:MDXG
US Market
Advertisement

MiMedx Group (MDXG) Earnings Dates, Call Summary & Reports

Compare
484 Followers

Earnings Data

Report Date
Mar 04, 2026
Before Open (Not Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.08
Last Year’s EPS
0.05
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 29, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a strong performance for the third quarter with record revenue and significant growth in major business areas. However, uncertainty around upcoming Medicare reimbursement reforms and ongoing legal expenses were highlighted as potential challenges. The company expressed confidence in its ability to navigate these uncertainties and continue its growth trajectory.
Company Guidance
During the MiMedx Third Quarter 2025 Operating and Financial Results Conference Call, the company reported robust performance with significant financial metrics. The net sales for the third quarter reached a record $114 million, reflecting a remarkable year-over-year growth of 35%. The adjusted EBITDA was noteworthy at $35 million, representing 31% of net sales, while the adjusted gross profit margin stood at an impressive 88%. MiMedx ended the quarter with a substantial net cash position of $124 million, a sequential increase of $23 million. The Wound and Surgical franchises both contributed to this growth, with the Surgical segment alone showing a 26% increase. The company raised its full-year 2025 revenue growth guidance to the mid- to high-teens and anticipates an adjusted EBITDA margin of at least the mid-20s as a percentage of net sales. Looking ahead, MiMedx is preparing for Medicare reimbursement reforms expected at the start of 2026, leveraging its strong balance sheet and strategic initiatives to maintain its market-leading position.
Record-Setting Quarterly Revenue
The company achieved a record $114 million in quarterly revenue, representing a 35% year-over-year growth.
Strong Performance in Surgical and Wound Franchises
Surgical business grew by 26% and wound care by 40% year-over-year, contributing significantly to the company's overall growth.
Increased Full-Year Guidance
The company raised its full-year 2025 revenue growth outlook from low teens to mid- to high teens and expects adjusted EBITDA margin to be at least in the mid-20s.
Notable Cash Generation
The company generated $29 million in free cash flow for the quarter, with a net cash position of $124 million and expectations to exceed $150 million by year-end.
Positive Interim Analysis for EPIEFFECT
Over half of the target patients are enrolled in the EPIEFFECT trial, with favorable interim results, positioning the product for future reimbursement coverage.

MiMedx Group (MDXG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MDXG Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 04, 2026
2025 (Q4)
0.08 / -
0.05
Oct 29, 2025
2025 (Q3)
0.06 / 0.11
0.05120.00% (+0.06)
Jul 30, 2025
2025 (Q2)
0.05 / 0.06
0.12-50.00% (-0.06)
Apr 30, 2025
2025 (Q1)
0.05 / 0.05
0.06-16.67% (>-0.01)
Feb 26, 2025
2024 (Q4)
0.07 / 0.05
0.32-84.38% (-0.27)
Oct 30, 2024
2024 (Q3)
0.04 / 0.05
0.06-16.67% (>-0.01)
Jul 30, 2024
2024 (Q2)
0.07 / 0.12
0
Apr 30, 2024
2024 (Q1)
0.04 / 0.06
-0.06200.00% (+0.12)
Feb 28, 2024
2023 (Q4)
0.07 / 0.32
-0.021700.00% (+0.34)
Oct 30, 2023
2023 (Q3)
0.05 / 0.06
-0.09166.67% (+0.15)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MDXG Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 29, 2025
$7.19
Jul 30, 2025
$6.52$7.19+10.28%
Apr 30, 2025
$6.88$6.32-8.14%
Feb 26, 2025
$8.01$8.14+1.62%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MiMedx Group Inc. (MDXG) report earnings?
MiMedx Group Inc. (MDXG) is schdueled to report earning on Mar 04, 2026, Before Open (Not Confirmed).
    What is MiMedx Group Inc. (MDXG) earnings time?
    MiMedx Group Inc. (MDXG) earnings time is at Mar 04, 2026, Before Open (Not Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MDXG EPS forecast?
          MDXG EPS forecast for the fiscal quarter 2025 (Q4) is 0.08.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis